Navigation Links
Particle Sciences and NETZSCH Premier Technologies Enter into Collaboration
Date:3/5/2013

BETHLEHEM, Pa., March 5, 2013 /PRNewswire/ -- Particle Sciences, a leading drug delivery CRO, has teamed up with NETZSCH Premier Technologies, a leading manufacturer of wet milling and dispersing equipment, to provide drug developers with improved access to state-of-the-art pharmaceutical nanomilling equipment and full pharmaceutical development capabilities.  According to Robert Lee , PhD, Vice President Pharmaceutical Development, "Particle Sciences has been using particle size reduction – in both dry and liquid-dispersed states – for decades.  With this collaboration, we acquired a NETZSCH DELTAVITA® Mill, which is one of the premier systems for pharmaceutical applications.  There is a growing demand for wet-milled products, particularly with respect to sterile products.  In fact, we are currently working on approximately 20 milling projects – the majority being sterile products.  The additional capability allows our clients to get into the clinic faster with a commercially representative manufacturing process."  Particle Sciences focuses on commercially-ready, advanced drug delivery technologies and is FDA registered and licensed for all schedules of controlled substances.  Randall Smith , President of NETZSCH Premier Technologies adds, "Particle Sciences provides customers that are interested in wet milling access to full development capabilities, including being able to take their products from feasibility into preclinical testing then ultimately human clinical trials and commercialization.  They will be a valuable partner to fully demonstrate the utility of our equipment and we will work with them as they continue to expand."

Particle Sciences is an integrated provider of drug development services.  Particle Sciences focuses on BCS II/III/IV molecules, biologics and highly potent compounds through a variety of technologies including emulsions, gels, micro and nano-particulates, drug/device combination products, solid solutions and others. Through a full range of formulation, analytic, and manufacturing services, Particle Sciences provides pharmaceutical companies with a complete and seamless development solution that minimizes the time and risk between discovery and the clinic.  The company was founded in 1991 and is headquartered in Bethlehem, Pennsylvania.  Visit www.particlesciences.com, email info@particlesciences.com or contact us at (610) 861- 4701 for information.

NETZSCH Premier Technologies, LLC. is the North American subsidiary of the globally operated group of NETZSCH companies. NETZSCH is a leading manufacturer of wet grinding and dispersing machinery, including media milling, dispersing and de-aerating, and dry grinding and classification machinery from lab research to full-scale production in the following applications: agriculture, adhesives, biotech, coating chocolate, cosmetics, drug discovery, environmental, food and beverage, inks and paints, minerals, nanotechnology, pharmaceutical, renewable energy, and technical ceramics.

Located in Exton, Pennsylvania, a western suburb of Philadelphia, their 85,000-square-foot facility contains engineering and manufacturing space, testing laboratories, and marketing and corporate offices.

With access to comprehensive global resources, NETZSCH customers can rely on their rigorous standards in design, engineering and manufacturing to deliver products with reliability, scalability and exceptional quality. NETZSCH service, like NETZSCH quality, is geared to surpass their customers' expectations. Their full-service capabilities in the areas of functional design, development, production, sales and service meet the highest demands established by the ISO 9001 International Quality Guidelines.

Contact: Maureen Mattera
mmattera@particlesciences.com



'/>"/>
SOURCE Particle Sciences Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Particle Sciences Develops Novel Ocular Formulation for Eyeon Therapeutics
2. Varian Medical Systems Signs Purchase Agreement with Advanced Particle Therapy LLC to Supply Technology for the Georgia Proton Treatment Center to be operated by Emory Healthcare
3. Sigma-Aldrich Accelerates Analytical Research and Extends Benefits of Fused-Core Particle Technology to All HPLC Users with the Launch of New Ascentis Express 5 Micron Particle by Supelco
4. Aethlon Medical Announces Notice of Allowance of U.S. Patent Application Covering a Medical Device to Remove Microvesicular Particles, Including Exosomes
5. Particle Sciences Expands its cGMP Capabilities with the Addition of Thin Films
6. Particle Measuring Systems® Celebrates 40 Years of Leadership
7. Dr. Joachim Schorr (PhD) zum Chief Scientific Officer von Caris Life Sciences bestellt
8. Joachim Schorr, PhD, Named Chief Scientific Officer at Caris Life Sciences
9. Presage Biosciences Announces Strategic Research Alliance with Celgene Corporation
10. Heptares to Present at the 6th Annual European Life Sciences CEO Forum (5-6 March)
11. Sangamo BioSciences Announces Presentation At 33rd Annual Cowen And Company Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)... SEOUL, South Korea , Oct. 4, 2017 /PRNewswire/ ... launched its next-generation CPR training aide "cprCUBE" on Kickstarter. ... of chest compression during cardiac arrests with better efficiency ... patient-mannequins. It also offers real-time feedback on efficacy of ... The crowdfunding campaign has a goal to raise ...
(Date:10/2/2017)... Lilly and Company (NYSE: LLY ) will ... 2017 on Tuesday, October 24, 2017. Lilly will also ... investment community and media to further detail the company,s ... at 9 a.m. Eastern time. Investors, media and the ... conference call through a link that will be posted ...
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated ... in breathing. Oral appliances can offer significant relief to about 75 percent of ...
(Date:10/12/2017)... , ... October 12, 2017 , ... IsoComforter, Inc. ( ... announced today the introduction of an innovative new design of the shoulder pad. ... you get maximum comfort while controlling your pain while using cold therapy. By utilizing ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
(Date:10/12/2017)... ... , ... Leading pediatric oncology experts at Children’s National Health System ... of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by ... Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief of the ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy ... health literacy software tool, and the Cancer Patient Education Network (CPEN), an independent ... today announce a new strategic alliance. , As CPEN’s strategic partner, HLI ...
Breaking Medicine News(10 mins):